B. Riley Wealth Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,244
Closed -$512K 1362
2024
Q2
$512K Sell
1,244
-21
-2% -$8.32K 0.01% 806
2024
Q1
$306K Buy
1,265
+11
+0.9% +$3.87K 0.01% 1027
2023
Q4
$384K Sell
1,254
-11
-0.9% -$2.97K 0.01% 947
2023
Q3
$306K Buy
1,265
+10
+0.8% +$2.56K 0.01% 1027
2023
Q2
$301K Sell
1,255
-1,570
-56% -$326K 0.01% 1121
2023
Q1
$531K Buy
2,825
+753
+36% +$156K 0.01% 781
2022
Q4
$440K Buy
+2,072
New +$414K 0.01% 845
2022
Q1
Sell
-2,124
Closed -$463K 1461
2021
Q4
$463K Buy
2,124
+7
+0.3% +$1.47K 0.01% 855
2021
Q3
$401K Sell
2,117
-56
-3% -$10.2K 0.01% 890
2021
Q2
$384K Buy
2,173
+54
+3% +$9.32K 0.01% 899
2021
Q1
$348K Sell
2,119
-63
-3% -$9.64K 0.01% 915
2020
Q4
$305K Sell
2,182
-102
-4% -$12.9K 0.02% 749
2020
Q3
$254K Buy
+2,284
New +$264K 0.01% 766

Other funds holding MEDP

B. Riley Wealth Advisors's MEDP Position: Q3 2024 in Review

B. Riley Wealth Advisors sold out of Medpace (MEDP) in Q3 2024, closing a stake of 1,244 shares — an estimated $512K sold.

B. Riley Wealth Advisors first reported a position in MEDP in Q3 2020 and held it in 13 quarters. The position peaked at $531K in Q1 2023. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • B. Riley Wealth Advisors reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 1,244 Medpace shares in Q3 2024, an estimated $512K.
  • B. Riley Wealth Advisors first reported a position in Medpace in Q3 2020 and held it in 13 quarters.
  • B. Riley Wealth Advisors's Medpace position peaked at $531K in Q1 2023.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2024, filed 13 Dec 2024.